Literature DB >> 10931272

Lewis antigens in Helicobacter pylori: biosynthesis and phase variation.

G Wang1, Z Ge, D A Rasko, D E Taylor.   

Abstract

The lipopolysaccharides (LPS) of most Helicobacter pylori strains contain complex carbohydrates known as Lewis antigens that are structurally related to the human blood group antigens. Investigations on the genetic determinants involved in the biosynthesis of Lewis antigens have led to the identification of the fucosyltransferases of H. pylori, which have substrate specificities distinct from the mammalian fucosyltransferases. Compared with its human host, H. pylori utilizes a different pathway to synthesize the difucosylated Lewis antigens, Lewis y. and Lewis b. Unique features in the H. pylori fucosyltransferase genes, including homopolymeric tracts mediating slipped-strand mispairing and the elements regulating translational frameshifting, enable H. pylori to produce variable LPS epitopes on its surface. These new findings have provided us with a basis to further examine the roles of molecular mimicry and phase variation of H. pylori Lewis antigen expression in both persistent infection and pathogenesis of this important human gastric pathogen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931272     DOI: 10.1046/j.1365-2958.2000.01934.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  58 in total

Review 1.  Helicobacter pylori genetic diversity and risk of human disease.

Authors:  M J Blaser; D E Berg
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Helicobacter hepaticus Hh0072 gene encodes a novel alpha1-3-fucosyltransferase belonging to CAZy GT11 family.

Authors:  Lei Zhang; Kam Lau; Jiansong Cheng; Hai Yu; Yanhong Li; Go Sugiarto; Shengshu Huang; Li Ding; Vireak Thon; Peng G Wang; Xi Chen
Journal:  Glycobiology       Date:  2010-05-06       Impact factor: 4.313

4.  Integrative genomic, transcriptional, and proteomic diversity in natural isolates of the human pathogen Burkholderia pseudomallei.

Authors:  Keli Ou; Catherine Ong; Shze Yung Koh; Fiona Rodrigues; Siew Hoon Sim; Daniel Wong; Chia Huey Ooi; Kim Chong Ng; Hiroyuki Jikuya; Chin Chin Yau; Sou Yen Soon; Djohan Kesuma; May Ann Lee; Patrick Tan
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

5.  Glycomimicry: display of fucosylation on the lipo-oligosaccharide of recombinant Escherichia coli K12.

Authors:  Elif Yavuz; Carola Maffioli; Karin Ilg; Markus Aebi; Bernard Priem
Journal:  Glycoconj J       Date:  2011-02-01       Impact factor: 2.916

6.  Host Lewis phenotype-dependent Helicobacter pylori Lewis antigen expression in rhesus monkeys.

Authors:  Hans-Peter Wirth; Manqiao Yang; Edgardo Sanabria-Valentín; Douglas E Berg; André Dubois; Martin J Blaser
Journal:  FASEB J       Date:  2006-05-23       Impact factor: 5.191

Review 7.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

Review 8.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Functional analysis of iceA1, a CATG-recognizing restriction endonuclease gene in Helicobacter pylori.

Authors:  Qing Xu; R D Morgan; R J Roberts; S Y Xu; L J van Doorn; J P Donahue; G G Miller; Martin J Blaser
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

10.  A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization.

Authors:  Anna Skoglund; Helene Kling Bäckhed; Christina Nilsson; Britta Björkholm; Staffan Normark; Lars Engstrand
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.